SCHEMBL1370917

SCHEMBL1370917

CCOC(=O)C(C)=[N+]=[N-]

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL28779486 0.82 TSHR (0.38)
SCHEMBL28779484 0.79 ALDH1A1 (0.54)
SCHEMBL2204826 0.78 ALDH1A1 (0.43)
SCHEMBL962321 0.77 GLO1 (0.47)
SCHEMBL28598310 0.76 GAA (0.56)
SCHEMBL28779472 0.76 TSHR (0.55)
SCHEMBL28779495 0.76 TSHR (0.59)
SCHEMBL28779475 0.76 TSHR (0.59)
SCHEMBL2927909 0.74
SCHEMBL1372367 0.74 SOAT1 (0.42)

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 57 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-103193662-A Method for preparing Beta-amino ester through copper-catalyzed three-component coupling reaction UNIV BEIJING SCIENCE & TECH 2013-07-10 CN claimed
CN-102295582-A Preparation method of alpha, beta-diamino acid derivatives with alpha-quaternary carbon 2011-12-28 CN claimed
US-20260049089-A1 KRAS INHIBITOR COMPOUND SHANGHAI APEIRON THERAPEUTICS COMPANY LIMITED (CN) 2026-02-19 US disclosed
US-12502376-B2 Pyrano[4,3-b]indole derivatives as alpha-1-antitrypsin modulators for treating alpha-1-antitrypsin deficiency (AATD) VERTEX PHARMACEUTICALS INCORPORATED (US) 2025-12-23 US disclosed
CN-114591217-B Preparation method of 6, 6-dimethyl-3-azabicyclo- [3.1.0] -hexane and lactone intermediate thereof 浙江新和成股份有限公司 2024-04-16 CN disclosed
WO-2024022471-A1 KRAS INHIBITOR COMPOUND 上海湃隆生物科技有限公司 2024-02-01 WO disclosed
US-20230339915-A1 MODULATORS OF ALPHA-1 ANTITRYPSIN VERTEX PHARMACEUTICALS INCORPORATED 2023-10-26 US disclosed
US-11766433-B2 Small molecule inhibitors of the nuclear translocation of androgen receptor for the treatment of castration-resistant prostate cancer UNIVERSITY OF PITTSBURGH - OF THE COMMONWEALTH SYSTEM OF HIGHER EDUCATION (US) 2023-09-26 US disclosed
US-20230157999-A1 PYRANO[4,3-B]INDOLE DERIVATIVES AS ALPHA-1-ANTITRYPSIN MODULATORS FOR TREATING ALPHA-1-ANTITRYPSIN DEFICIENCY (AATD) VERTEX PHARMACEUTICALS (SAN DIEGO) LLC 2023-05-25 US disclosed
CN-115916749-A Substituted 5-hydroxyindole compounds as alpha-1 antitrypsin modulators 弗特克斯药品有限公司 2023-04-04 CN disclosed
CN-115768772-A Pyrano [4,3-b ] L indole derivatives as alpha-1 antitrypsin modulators for the treatment of alpha-1 antitrypsin deficiency (AATD) 弗特克斯药品有限公司 2023-03-07 CN disclosed
US-20100197683-A1 FUSED RING COMPOUND AND USE THEREOF TAKEDA PHARMACEUTICAL COMPANY LIMITED 2010-08-05 US disclosed
WO-2010087515-A1 FUSED RING COMPOUND AND USE THEREOF TAKEDA PHARMACEUTICAL COMPANY LIMITED (JP) 2010-08-05 WO disclosed
US-20100029740-A1 AZABICYCLIC COMPOUNDS AS SEROTONIN, DOPAMINE AND NOREPINEPHRINE RE-UPTAKE INHIBITORS BONANOMI GIORGIO 2010-02-04 US disclosed
US-20100029740-A1 AZABICYCLIC COMPOUNDS AS SEROTONIN, DOPAMINE AND NOREPINEPHRINE RE-UPTAKE INHIBITORS BONANOMI GIORGIO 2010-02-04 US disclosed
EP-2094657-A1 AZABICYCLIC COMPOUNDS AS SEROTONINE, DOPAMINE AND NOREPINEPHRINE RE-UPTAKE INHIBITORS Glaxo Group Limited (GB) 2009-09-02 EP disclosed
WO-2008074716-A1 AZABICYCLIC COMPOUNDS AS SEROTONINE, DOPAMINE AND NOREPINEPHRINE RE-UPTAKE INHIBITORS GLAXO GROUP LIMITED (GB) 2008-06-26 WO disclosed
EP-0397175-B1 Substituted pyrrolizine compounds and theit use as pharmaceuticals DANNHARDT GERD PROF DR (DE) 1993-12-08 EP disclosed
US-5260451-A Enzyme inhibitors MERCKLE GMBH (DE) 1993-11-09 US disclosed
EP-0397175-A1 Substituted pyrrolizine compounds and theit use as pharmaceuticals Dannhardt, Gerd, Prof.Dr. (DE) 1990-11-14 EP disclosed